Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Nurix Therapeutics Inc., 3 years.
Nurix Therapeutics Inc.
Director
Oric Pharmaceuticals Inc.
Director
Enliven Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Enliven Therapeutics Inc. June 9, 202664.7%
-
Oric Pharmaceuticals Inc. June 12, 202499.0%
-
Nurix Therapeutics Inc. May 4, 202387.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 6, 2026 | Enliven Therapeutics Inc. | Open-market sale | −4,111 | $49.98 | $205,482 |
| Jul 6, 2026 | Enliven Therapeutics Inc. | Open-market sale | −5,889 | $50.84 | $299,421 |
| Jun 5, 2026 | Enliven Therapeutics Inc. | Open-market sale | −7,779 | $34.28 | $266,664 |
| Jun 5, 2026 | Enliven Therapeutics Inc. | Open-market sale | −1,867 | $35.36 | $66,017 |
| Jun 5, 2026 | Enliven Therapeutics Inc. | Open-market sale | −354 | $35.82 | $12,680 |
| Dec 17, 2025 | Enliven Therapeutics Inc. | Option exercise | +15,958 | $1.12 | $17,873 |
| Dec 8, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +10,000 | $7.90 | $79,000 |
| Dec 4, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +5,534 | $3.75 | $20,753 |
| Mar 3, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +27,666 | $3.75 | $103,748 |
| Mar 3, 2025 | Oric Pharmaceuticals Inc. | Option exercise | +20,500 | $6.33 | $129,765 |
| Jul 17, 2024 | Nurix Therapeutics Inc. | Gift | −54,027 | — | — |
| Jun 3, 2024 | Oric Pharmaceuticals Inc. | Option exercise | +20,500 | $3.75 | $76,875 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.